Dr. Victor Dzau, chancellor for health affairs and CEO, Duke University Health System, and Dr. Geoffrey Ginsburg, executive director, Center for Personalized Medicine, are holding the Duke Center for Personalized Medicine 2012 Symposium on March 29 from 8:30 a.m. to 5:30 p.m. at Duke University School of Nursing (DUSON). Theme for the gathering is “The Interface of Research and Clinical Implementation.”
The event will engage Duke faculty, invited guest speakers, panelists, and clinicians in discussions about pharmacogenomics, clinical implementation and outcomes, policy and education, and the value of personalized medicine.
The panelists from DUSON are Dean Catherine L. Gilliss, DNSc, RN, FAAN, Helene Fuld Health Trust Professor of Nursing and vice chancellor for nursing affairs, Duke University, who will serve on the “Adopting Personalized Medicine: Identifying the Policy and Educational Strategies” panel, and Allison A. Vorderstrasse, DNSc, MSN, APRN, assistant professor, who will serve on “The Partnering of Genomic Medicine and Clinical Medicine: Making it Happen” panel.
About DUSONDuke University School of Nursing (DUSON), as a diverse community of scholars and clinicians, educates the next generation of transformational leaders in nursing, advances nursing science in issues of global import, and fosters the scholarly practice of nursing. In 2011, US News and World Report ranked Duke among the top seven graduate schools of nursing in the nation. The School offers masters, PhD, and doctor of nursing practice degrees, as well as an accelerated bachelor of science in nursing degree to students who have previously completed an undergraduate degree. More than 800 individuals enrolled for Spring 2012 classes, the largest number of students in the School’s 80-year history.